WellPoint Inc (WLP): Today's Featured Health Care Winner

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

WellPoint ( WLP) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day up 1.0%. By the end of trading, WellPoint rose $1.43 (1.7%) to $86.92 on average volume. Throughout the day, 2,161,243 shares of WellPoint exchanged hands as compared to its average daily volume of 2,260,800 shares. The stock ranged in a price between $85.54-$87.26 after having opened the day at $85.78 as compared to the previous trading day's close of $85.49. Other companies within the Health Care sector that increased today were: Thermogenesis Corporation ( KOOL), up 111.0%, ImmunoCellular Therapeutics ( IMUC), up 32.8%, Mast Therapeutics ( MSTX), up 29.6% and iBio ( IBIO), up 28.0%.

WellPoint, Inc., a health benefits company, through its subsidiaries, offers network-based managed care plans to large and small employer, individual, Medicaid, and senior markets in the United States. The company operates through three segments: Commercial, Consumer, and Other. WellPoint has a market cap of $25.3 billion and is part of the health services industry. The company has a P/E ratio of 9.2, below the S&P 500 P/E ratio of 17.7. Shares are down 7.5% year to date as of the close of trading on Friday. Currently there are 5 analysts that rate WellPoint a buy, no analysts rate it a sell, and 11 rate it a hold.

TheStreet Ratings rates WellPoint as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, attractive valuation levels and good cash flow from operations. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

On the negative front, Amarin Corporation ( AMRN), down 23.8%, Liberator Medical Holdings ( LBMH), down 21.2%, Nanoviricides ( NNVC), down 17.5% and NovaBay Pharmaceuticals ( NBY), down 12.5% , were all laggards within the health care sector with Endo Health Solutions ( ENDP) being today's health care sector laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

How Walmart and Costco Could See a Future Flush With Profits Thanks to an Abundance of Cute Puppies

How Walmart and Costco Could See a Future Flush With Profits Thanks to an Abundance of Cute Puppies

U.S. Stocks Open Higher as Anthem Buys Cigna in $54 Billion Deal

U.S. Stocks Open Higher as Anthem Buys Cigna in $54 Billion Deal

Anthem Buying Cigna in $54.2 Billion Cash and Stock Deal

Anthem Buying Cigna in $54.2 Billion Cash and Stock Deal

Cigna Shares Soar on Reports of $48 Billion Anthem Buyout

Cigna Shares Soar on Reports of $48 Billion Anthem Buyout

Anthem’s Massive Data Breach Could Affect Customers for Years

Anthem’s Massive Data Breach Could Affect Customers for Years